Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy


Kaderli B., Avci R., Yucel A., Guler K., Gelisken O.

JOURNAL OF NEURO-OPHTHALMOLOGY, cilt.27, sa.3, ss.164-168, 2007 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 3
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1097/wno.0b013e31814a5a9a
  • Dergi Adı: JOURNAL OF NEURO-OPHTHALMOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.164-168
  • Bursa Uludağ Üniversitesi Adresli: Hayır

Özet

Background: The visual outcome in untreated non-arteritic anterior ischemic optic neuropathy (NAION) is dismal. Because intravitreal triamcinolone (IVTA) has shown promise in improving edematous retinal disorders, a pilot trial of this therapy in NAION was considered reasonable.